Tag Archives: OFEV

Drug-Induced Liver Injury Warning Added To OFEV Label In Canada As Done Earlier In US

This Relatively New Idiopathic Pulmonary Fibrosis (IPF) Pill Is Clearly On The Radar Of Drug Safety Regulators   (Posted by Tom Lamb at DrugInjuryWatch.com)   OFEV (nintedanib) capsules were approved by the FDA in 2014 for treatment of idiopathic pulmonary fibrosis … Continue reading

Posted in Health Law | Tagged , , , , , , , , , | Leave a comment